Gut Akkermansia muciniphila ameliorates metabolic dysfunction-associated fatty liver disease by regulating the metabolism of L-aspartate via gut-liver axis

Trimmomatic: a flexible trimmer for Illumina sequence data

Bolger, A. M., Lohse, M., & Usadel, B. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu170 · Cited by 65,548 · see citing works

Cross-talk between <i>Akkermansia muciniphila</i> and intestinal epithelium controls diet-induced obesity

Everard, A., Belzer, C., Geurts, L., Ouwerkerk, J. P., Druart, C., Bindels, L. B., Guiot, Y., Derrien, M., Muccioli, G. G., Delzenne, N. M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219451110 · Cited by 4,511 · see citing works

Mechanisms of NAFLD development and therapeutic strategies

Friedman, S. L., Neuschwander-Tetri, B. A., Rinella, M., & Sanyal, A. J. (2018) · Nature Medicine · doi:10.1038/s41591-018-0104-9 · Cited by 4,354 · see citing works

Animal research: Reporting <i>in vivo</i> experiments: The ARRIVE guidelines

Kilkenny, C., Browne, W., Cuthill, I. C., Emerson, M., & Altman, D. G. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00872.x · Cited by 3,625 · see citing works

NAFLD: A multisystem disease

Byrne, C. D., & Targher, G. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.12.012 · Cited by 3,082 · see citing works

Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism

Wahlstrom, A. M., Sayin, S. I., Marschall, H., & Bäckhed, F. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.05.005 · Cited by 2,903 · see citing works

Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: A proof-of-concept exploratory study

Depommier, C., Everard, A., Druart, C., Plovier, H., Van Hul, M., Vieira-Silva, S., Falony, G., Raes, J., Maiter, D., Delzenne, N. M., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0495-2 · Cited by 2,357 · see citing works

A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice

Plovier, H., Everard, A., Druart, C., Depommier, C., Van Hul, M., Geurts, L., Chilloux, J., Ottman, N., Duparc, T., Lichtenstein, L., et al. (2017) · Nature Medicine · doi:10.1038/nm.4236 · Cited by 2,204 · see citing works

The gut-liver axis in liver disease: Pathophysiological basis for therapy

Albillos, A., de Gottardi, A., & Rescigno, M. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2019.10.003 · Cited by 2,166 · see citing works

Animal Research: Reporting <i>in vivo</i> Experiments—The ARRIVE Guidelines

Kilkenny, C., Browne, W., Cuthill, I. C., Emerson, M., & Altman, D. G. (2011) · Journal of Cerebral Blood Flow &amp; Metabolism · doi:10.1038/jcbfm.2010.220 · Cited by 2,012 · see citing works

Gut microbiome structure and metabolic activity in inflammatory bowel disease

Franzosa, E. A., Sirota-Madi, A., Avila-Pacheco, J., Fornelos, N., Haiser, H. J., Reinker, S., Vatanen, T., Hall, A. B., Mallick, H., McIver, L. J., et al. (2018) · Nature Microbiology · doi:10.1038/s41564-018-0306-4 · Cited by 1,995 · see citing works

Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis

Jia, W., Xie, G., & Jia, W. (2018) · Nature Reviews Gastroenterology &amp; Hepatology · doi:10.1038/nrgastro.2017.119 · Cited by 1,924 · see citing works

An insight into gut microbiota and its functionalities

Adak, A., & Khan, M. R. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2943-4 · Cited by 1,485 · see citing works

Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewers

Curtis, M. J., Alexander, S., Cirino, G., Docherty, J. R., George, C. H., Giembycz, M. A., Hoyer, D., Insel, P. A., Izzo, A. A., Ji, Y., et al. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14153 · Cited by 1,338 · see citing works

Implementing guidelines on reporting research using animals ( <scp>ARRIVE</scp> etc.): new requirements for publication in <scp>BJP</scp>

McGrath, J. C., & Lilley, E. (2015) · British Journal of Pharmacology · doi:10.1111/bph.12955 · Cited by 1,321 · see citing works

Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis

Diehl, A. M., & Day, C. (2017) · New England Journal of Medicine · doi:10.1056/nejmra1503519 · Cited by 1,283 · see citing works

A polyphenol-rich cranberry extract protects from diet-induced obesity, insulin resistance and intestinal inflammation in association with increased <i>Akkermansia</i> spp. population in the gut microbiota of mice

Anhê, F. F., Roy, D., Pilon, G., Dudonné, S., Matamoros, S., Varin, T. V., Garofalo, C., Moine, Q., Desjardins, Y., Levy, E., et al. (2015) · Gut · doi:10.1136/gutjnl-2014-307142 · Cited by 1,137 · see citing works

Short-Chain Fatty Acids Protect Against High-Fat Diet–Induced Obesity via a PPARγ-Dependent Switch From Lipogenesis to Fat Oxidation

den Besten, G., Bleeker, A., Gerding, A., van Eunen, K., Havinga, R., van Dijk, T. H., Oosterveer, M. H., Jonker, J. W., Groen, A. K., Reijngoud, D.-J., et al. (2015) · Diabetes · doi:10.2337/db14-1213 · Cited by 1,125 · see citing works

The interaction of hepatic lipid and glucose metabolism in liver diseases

Bechmann, L. P., Hannivoort, R. A., Gerken, G., Hotamışlıgil, G. S., Trauner, M., & Canbay, A. E. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.08.025 · Cited by 992 · see citing works

Triggering and resolution of inflammation in NASH

Schuster, S., Cabrera, D., Arrese, M., & Feldstein, A. E. (2018) · Nature Reviews Gastroenterology &amp; Hepatology · doi:10.1038/s41575-018-0009-6 · Cited by 943 · see citing works

Lipotoxicity and the gut-liver axis in NASH pathogenesis

Marra, F., & Svegliati-Baroni, G. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2017.11.014 · Cited by 847 · see citing works

Dietary cholesterol drives fatty liver-associated liver cancer by modulating gut microbiota and metabolites

Zhang, X., Coker, O. O., Chu, E. S., Fu, K., Lau, H. C. H., Wang, Y.-X., Chan, A. W. H., Wei, H., Yang, X., Sung, J. J. Y., et al. (2021) · Gut · doi:10.1136/gutjnl-2019-319664 · Cited by 841 · see citing works

Human Gut Microbiome: Function Matters

Heintz‐Buschart, A., & Wilmes, P. (2017) · Trends in Microbiology · doi:10.1016/j.tim.2017.11.002 · Cited by 747 · see citing works

Nonalcoholic fatty liver disease as a nexus of metabolic and hepatic diseases

Samuel, V. T., & Shulman, G. I. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2017.08.002 · Cited by 745 · cited 1× · see citing works

<i>Akkermansia muciniphila</i> is a promising probiotic

Zhang, T., Li, Q., Cheng, L., Buch, H., & Zhang, F. (2019) · Microbial Biotechnology · doi:10.1111/1751-7915.13410 · Cited by 708 · see citing works

Bile acids and nonalcoholic fatty liver disease: Molecular insights and therapeutic perspectives

Arab, J. P., Karpen, S. J., Dawson, P. A., Arrese, M., & Trauner, M. (2017) · Hepatology · doi:10.1002/hep.28709 · Cited by 634 · see citing works

Differences in gut microbiota in patients with vs without inflammatory bowel diseases: A systematic review

Pittayanon, R., Lau, J. T., Leontiadis, G. I., Tse, F., Yuan, Y., Surette, M., & Moayyedi, P. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.11.294 · Cited by 623 · see citing works

Recovery of ethanol-induced <i>Akkermansia muciniphila</i> depletion ameliorates alcoholic liver disease

Grander, C., Adolph, T. E., Wieser, V., Lowe, P., Wrzosek, L., Gyongyosi, B., Ward, D. V., Grabherr, F., Gerner, R. R., Pfister, A., et al. (2018) · Gut · doi:10.1136/gutjnl-2016-313432 · Cited by 618 · see citing works

Gut microbiota and metabolic syndrome

Festi, D., Schiumerini, R., Eusebi, L. H., Marasco, G., Taddia, M., & Colecchia, A. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i43.16079 · Cited by 534 · see citing works

Administration of Akkermansia muciniphila Ameliorates Dextran Sulfate Sodium-Induced Ulcerative Colitis in Mice

Bian, X., Wu, W., Yang, L., Lv, L., Wang, Q., Li, Y., Ye, J., Fang, D., Wu, J., Jiang, X., et al. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02259 · Cited by 529 · see citing works

Bile acids in glucose metabolism in health and disease

Shapiro, H., Kolodziejczyk, A. A., Halstuch, D., & Elinav, E. (2018) · The Journal of Experimental Medicine · doi:10.1084/jem.20171965 · Cited by 467 · see citing works

Role of bile acids in metabolic control

Molinaro, A., Wahlström, A., & Marschall, H.-U. (2018) · Trends in Endocrinology &amp; Metabolism · doi:10.1016/j.tem.2017.11.002 · Cited by 447 · see citing works

Acute appendicitis is characterised by local invasion with Fusobacterium nucleatum / necrophorum

Swidsinski, A. V., Dörffel, Y., Loening-Baucke, V. A., Theissig, F., Rueckert, J.-C., Ismail, M., Rau, W. A., Gaschler, D., Weizenegger, M., Kühn, S., et al. (2009) · Gut · doi:10.1136/gut.2009.191320 · Cited by 441 · see citing works

Update on NAFLD genetics: From new variants to the clinic

Trépo, E., & Valenti, L. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.02.020 · Cited by 393 · see citing works

Management of NAFLD: a stage-based approach

Rinella, M. E., & Sanyal, A. J. (2016) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.3 · Cited by 388 · see citing works

Metabolism and functions of l-glutamate in the epithelial cells of the small and large intestines

Blachier, F., Boutry, C., Bos, C., & Tomé, D. (2009) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.27462s · Cited by 334 · see citing works

Gut–liver axis, nutrition, and non-alcoholic fatty liver disease

Kirpich, I. A., Marsano, L. S., & McClain, C. J. (2015) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2015.06.023 · Cited by 327 · see citing works

Diet associated hepatic steatosis sensitizes to Fas mediated liver injury in mice

Feldstein, A. E., Canbay, A. E., Guicciardi, M. E., Higuchi, H., Bronk, S. F., & Gores, G. J. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00460-4 · Cited by 317 · see citing works

Akkermansia muciniphila improves metabolic profiles by reducing inflammation in chow diet-fed mice

Zhao, S., Liu, W., Wang, J., Shi, J., Sun, Y., Wang, W., Ning, G., Liu, R., & Hong, J. (2017) · Journal of Molecular Endocrinology · doi:10.1530/jme-16-0054 · Cited by 298 · see citing works

Transforming Growth Factor Beta Signaling in Hepatocytes Participates in Steatohepatitis Through Regulation of Cell Death and Lipid Metabolism in Mice

Yang, L., Roh, Y. S., Song, J., Zhang, B., Liu, C., Loomba, R., & Seki, E. (2014) · Hepatology · doi:10.1002/hep.26698 · Cited by 275 · see citing works

Pasteurized Akkermansia muciniphila increases whole-body energy expenditure and fecal energy excretion in diet-induced obese mice

Depommier, C., Hul, M. V., Everard, A., Delzenne, N. M., de Vos, W. M., & Cani, P. D. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1737307 · Cited by 270 · see citing works

Drosophila Histone Demethylase KDM5 Regulates Social Behavior through Immune Control and Gut Microbiota Maintenance

Chen, K., Luan, X., Liu, Q., Wang, J., Chang, X., Snijders, A. M., Mao, J.-H., Secombe, J., Dan, Z., Chen, J.-H., et al. (2019) · Cell Host &amp; Microbe · doi:10.1016/j.chom.2019.02.003 · Cited by 208 · see citing works

Tauroursodeoxycholic acid inhibits intestinal inflammation and barrier disruption in mice with non‐alcoholic fatty liver disease

Wang, W., Zhao, J., Gui, W., Sun, D., Dai, H., Xiao, L., Chu, H., Du, F., Zhu, Q., Schnabl, B., et al. (2017) · British Journal of Pharmacology · doi:10.1111/bph.14095 · Cited by 208 · see citing works

Importance of propionate for the repression of hepatic lipogenesis and improvement of insulin sensitivity in high‐fat diet‐induced obesity

Weitkunat, K., Schumann, S., Nickel, D., Kappo, K. A., Petzke, K. J., Kipp, A. P., Blaut, M., & Klaus, S. (2016) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201600305 · Cited by 183 · see citing works

Loss-of-function mutations in the glutamate transporter SLC1A1 cause human dicarboxylic aminoaciduria.

Bailey, C. G., Ryan, R. M., Thoeng, A. D., Ng, C., King, K., Vanslambrouck, J. M., Auray-Blais, C., Vandenberg, R. J., Bröer, S., & Rasko, J. E. J. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44474 · Cited by 162 · see citing works

Anti-obesity Effect of Capsaicin in Mice Fed with High-Fat Diet Is Associated with an Increase in Population of the Gut Bacterium Akkermansia muciniphila

Shen, W., Shen, M., Zhao, X., Zhu, H., Yang, Y., Lu, S., Tan, Y., Li, G., Li, M., Wang, J., et al. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00272 · Cited by 159 · see citing works

Gut microbiome and nonalcoholic fatty liver diseases

Zhu, L., Baker, R. D., & Baker, S. S. (2014) · Pediatric Research · doi:10.1038/pr.2014.157 · Cited by 143 · see citing works

Obesity treatment by epigallocatechin‐3‐gallate−regulated bile acid signaling and its enriched Akkermansia muciniphila

Sheng, L., Jena, P. K., Liu, H., Hu, Y. C., Nagar, N., Bronner, D. N., Settles, M. L., Bäumler, A. J., & Wan, Y. Y. (2018) · The FASEB Journal · doi:10.1096/fj.201800370r · Cited by 128 · see citing works

p53-mediated control of aspartate-asparagine homeostasis dictates LKB1 activity and modulates cell survival

Deng, L., Yao, P., Li, L., Ji, F., Zhao, S., Xu, C., Lan, X., & Jiang, P. (2020) · Nature Communications · doi:10.1038/s41467-020-15573-6 · Cited by 119 · see citing works

The Liver at the Nexus of Host-Microbial Interactions

Macpherson, A. J., Heikenwälder, M. F., & Ganal-Vonarburg, S. C. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.10.016 · Cited by 113 · see citing works

Malate and Aspartate Increase L-Arginine and Nitric Oxide and Attenuate Hypertension

Hou, E., Sun, N., Zhang, F., Zhao, C., Usa, K., Liang, M., & Tian, Z. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.04.071 · Cited by 96 · see citing works

SIRT1/HSF1/HSP pathway is essential for exenatide‐alleviated, lipid‐induced hepatic endoplasmic reticulum stress

Zheng, X., Xu, F. L., Liang, H., Cao, H., Cai, M., Xu, W., & Weng, J. (2017) · Hepatology · doi:10.1002/hep.29238 · Cited by 85 · see citing works

Reprogramming of Amino Acid Transporters to Support Aspartate and Glutamate Dependency Sustains Endocrine Resistance in Breast Cancer

Bacci, M., Lorito, N., Ippolito, L., Ramazzotti, M., Luti, S., Romagnoli, S., Parri, M., Bianchini, F., Cappellesso, F., Virga, F., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.06.010 · Cited by 85 · see citing works

Non-alcoholic fatty liver disease (NAFLD) models in drug discovery

Cole, B. K., Feaver, R. E., Wamhoff, B. R., & Dash, A. (2017) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2018.1410135 · Cited by 79 · see citing works

Advanced liver steatosis accompanies an increase in hepatic inflammation, colonic, secondary bile acids and Lactobacillaceae/Lachnospiraceae bacteria in C57BL/6 mice fed a high-fat diet

Zeng, H., Larson, K., Cheng, W., Bukowski, M. R., Safratowich, B. D., Liu, Z., & Hakkak, R. (2020) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2019.108336 · Cited by 74 · see citing works

miR-552-3p modulates transcriptional activities of FXR and LXR to ameliorate hepatic glycolipid metabolism disorder

Fan, L., Lai, R., Ma, N., Dong, Y., Li, Y., Wu, Q., Qiao, J., Lu, H., Gong, L., Tao, Z., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.07.048 · Cited by 70 · see citing works

Interleukin-36 cytokines alter the intestinal microbiome and can protect against obesity and metabolic dysfunction

Giannoudaki, E., Hernandez-Santana, Y., Mulfaul, K., Doyle, S., Hams, E., Fallon, P. G., Mat, A., O'Shea, D. B., Köpf, M., Hogan, A. E., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11944-w · Cited by 66 · see citing works

Colitis susceptibility in mice with reactive oxygen species deficiency is mediated by mucus barrier and immune defense defects

Aviello, G., Singh, A. K., O’Neill, S., Conroy, E., Gallagher, W. M., D’Agostino, G., Walker, A. W., Bourke, B., Scholz, D., & Knaus, U. G. (2019) · Mucosal Immunology · doi:10.1038/s41385-019-0205-x · Cited by 65 · see citing works

l-Ornithine l-Aspartate (LOLA) as a Novel Approach for Therapy of Non-alcoholic Fatty Liver Disease

Canbay, A. E., & Sowa, J. (2019) · Drugs · doi:10.1007/s40265-018-1020-5 · Cited by 57 · see citing works

Diverse effects of different Akkermansia muciniphila genotypes on Brown adipose tissue inflammation and whitening in a high-fat-diet murine model

Deng, L., Ou, Z., Huang, D., Li, C., Lü, Z., Liu, W., Wu, F., Nong, C., Gao, J., & Peng, Y. (2020) · Microbial Pathogenesis · doi:10.1016/j.micpath.2020.104353 · Cited by 55 · see citing works

Bile acid regulation: A novel therapeutic strategy in non-alcoholic fatty liver disease

Yu, Q., Jiang, Z., & Zhang, L. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.04.005 · Cited by 52 · see citing works

Aspartate alleviates liver injury and regulates mRNA expressions of TLR4 and NOD signaling-related genes in weaned pigs after lipopolysaccharide challenge

Leng, W., Liu, Y., Shi, H., Li, S., Zhu, H., Pi, D., Hou, Y., & Gong, J. (2014) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2014.01.010 · Cited by 50 · see citing works

Bouchardatine analogue alleviates non‐alcoholic hepatic fatty liver disease/non‐alcoholic steatohepatitis in high‐fat fed mice by inhibiting ATP synthase activity

Rao, Y., Lu, Y., Li, C., Song, Q., Xu, Y., Zhao, X. D., Hu, Y., Yu, H., Gao, L., Gu, L., et al. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14713 · Cited by 43 · see citing works

Pharmacological activation of REV-ERBα improves nonalcoholic steatohepatitis by regulating intestinal permeability

Ni, Y., Zhao, Y., Ma, L., Wang, Z., Ni, L., Hu, L., & Fu, Z. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154409 · Cited by 38 · see citing works

Dysfunctional d-aspartate metabolism in BTBR mouse model of idiopathic autism

Nuzzo, T., Sekine, M., Punzo, D., Miroballo, M., Katane, M., Saitoh, Y., Galbusera, A., Pasqualetti, M., Errico, F., Gozzi, A., et al. (2020) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2020.140531 · Cited by 33 · see citing works

Aspartic acid supplementation ameliorates symptoms of diabetic kidney disease in mice

Ichikawa, S., Gohda, T., Murakoshi, M., Li, Z., Adachi, E., Koshida, T., & Suzuki, Y. (2020) · FEBS Open Bio · doi:10.1002/2211-5463.12862 · Cited by 20 · see citing works

Impaired Chylomicron Assembly Modifies Hepatic Metabolism Through Bile Acid–Dependent and Transmissible Microbial Adaptations

Xie, Y., Matsumoto, H., Kennedy, S., Newberry, E. P., Moritz, W. R., DeBosch, B. J., Moley, K. H., Rubin, D. C., Warner, B. W., Kau, A. L., et al. (2019) · Hepatology · doi:10.1002/hep.30669 · Cited by 15 · see citing works

The Temporal Expression of Global Regulator Protein CsrA Is Dually Regulated by ClpP During the Biphasic Life Cycle of Legionella pneumophila

Ge, Z., Long, Q.-S., Yuan, P., Pan, X., Shen, D., & Lu, Y. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02495 · Cited by 10 · see citing works

75 Hepatic steatosis enhances FAS expression and liver injury in mice

Feldstein, A. E., Canbay, A. E., Guicciardi, M. E., Higuchi, H., & Gores, G. J. (2003) · Hepatology · doi:10.1016/s0270-9139(03)80118-0 · Cited by 2 · see citing works

Bile acid composition modulate insulin resistance in non-diabetic patients with NAFLD

Rosso, C., Younes, R., Eslam, M., Chen, F. W., Cucco, M., Gaggini, M., Coulter, S., Carli, F., Barbieri, C., Latta, V. D., et al. (2018) · Journal of Hepatology · doi:10.1016/s0168-8278(18)30895-x · Cited by 2 · see citing works

Gut symbionts alleviate MASH through a secondary bile acid biosynthetic pathway

Nie, Q., Luo, X., Wang, K., Ding, Y., Jia, S., Zhao, Q., Li, M., Zhang, J., Zhuo, Y., Lin, J., et al. (2024) · Cell · doi:10.1016/j.cell.2024.03.034 · Cited by 347 · see citing works

Gut microbiome-mediated mechanisms for reducing cholesterol levels: implications for ameliorating cardiovascular disease

Jia, B., Zou, Y., Han, X., Bae, J., & Jeon, C. O. (2022) · Trends in Microbiology · doi:10.1016/j.tim.2022.08.003 · Cited by 220 · see citing works

The Role of Gut–Liver Axis in Gut Microbiome Dysbiosis Associated NAFLD and NAFLD-HCC

Song, Q., & Zhang, X. (2022) · Biomedicines · doi:10.3390/biomedicines10030524 · Cited by 147 · see citing works

Beneficial effect of the short-chain fatty acid propionate on vascular calcification through intestinal microbiota remodelling

Yan, J., Pan, Y., Shao, W., Wang, C., Wang, R., He, Y., Zhang, M., Wang, Y., Li, T., Wang, Z., et al. (2022) · Microbiome · doi:10.1186/s40168-022-01390-0 · Cited by 148 · see citing works

<i>Akkermansia muciniphila</i> alleviates <scp>high‐fat‐diet</scp> ‐related metabolic‐associated fatty liver disease by modulating gut microbiota and bile acids

Wu, W., Kaicen, W., Bian, X., Yang, L., Ding, S., Li, Y., Li, S., Zhuge, A., & Li, L. (2023) · Microbial Biotechnology · doi:10.1111/1751-7915.14293 · Cited by 129 · see citing works

Revisiting the role of Akkermansia muciniphila as a therapeutic bacterium

Si, J., Kang, H., You, H. J., & Ko, G. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2078619 · Cited by 126 · see citing works

Theabrownin inhibits obesity and non-alcoholic fatty liver disease in mice via serotonin-related signaling pathways and gut-liver axis

Li, H., Huang, S., Zhou, D.-D., Xiong, R.-G., Luo, M., Saimaiti, A., Han, M.-K., Gan, R., Zhu, H., & Li, H. (2023) · Journal of Advanced Research · doi:10.1016/j.jare.2023.01.008 · Cited by 122 · see citing works

Inulin-enriched Megamonas funiformis ameliorates metabolic dysfunction-associated fatty liver disease by producing propionic acid

Yang, X., Zhang, M., Liu, Y., Wei, F., Li, X., Feng, Y., Jin, X., Liu, D., Guo, Y., & Hu, Y. (2023) · npj Biofilms and Microbiomes · doi:10.1038/s41522-023-00451-y · Cited by 112 · see citing works

Akkermansia muciniphila plays critical roles in host health

Zhao, Q., Yu, J., Hao, Y., Zhou, H., Hu, Y., Zhang, C., Zheng, H., Wang, X., Zeng, F., Hu, J., et al. (2022) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2022.2037506 · Cited by 101 · see citing works

Longitudinal 16S rRNA Sequencing Reveals Relationships among Alterations of Gut Microbiota and Nonalcoholic Fatty Liver Disease Progression in Mice

Zhuge, A., Li, S., Lou, P., Wu, W., Wang, K., Yuan, Y., Xia, J., Li, B., & Li, L. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.00047-22 · Cited by 100 · see citing works

Akkermansia muciniphila: A key player in gut microbiota-based disease modulation

Shaheen, N., Khursheed, W., Gurung, B., & Wang, S. (2025) · Microbiological Research · doi:10.1016/j.micres.2025.128317 · Cited by 99 · see citing works

Akkermansia muciniphila: a potential candidate for ameliorating metabolic diseases

Niu, H., Zhou, M., Zogona, D., Xing, Z., Wu, T., Chen, R., Cui, D., Liang, F., & Xu, X. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1370658 · Cited by 98 · see citing works

Role of Akkermansia in Human Diseases: From Causation to Therapeutic Properties

Pellegrino, A., Coppola, G., Santopaolo, F., Gasbarrini, A., & Ponziani, F. R. (2023) · Nutrients · doi:10.3390/nu15081815 · Cited by 105 · see citing works

Gut microbiota and metabolic biomarkers in metabolic dysfunction–associated steatotic liver disease

Long, Q., Luo, F., Li, B., Li, Z., Guo, Z., Chen, Z., Wu, W., & Hu, M. (2024) · Hepatology Communications · doi:10.1097/hc9.0000000000000310 · Cited by 94 · see citing works

Akkermansia muciniphila-derived acetate activates the hepatic AMPK/SIRT1/PGC-1α axis to alleviate ferroptosis in metabolic-associated fatty liver disease

Zhuge, A., Li, S., Han, S., Yuan, Y., Shen, J., Wu, W., Wang, K., Xia, J., Wang, Q., Gu, Y., et al. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.10.010 · Cited by 94 · see citing works

PGAM1 Inhibition Promotes HCC Ferroptosis and Synergizes with Anti‐PD‐1 Immunotherapy

Zheng, Y.-M., Wang, Y., Zhou, L., Wan, J., Jiang, L., Song, D., Wei, C., Gao, C., Shi, G., Zhou, J., et al. (2023) · Advanced Science · doi:10.1002/advs.202301928 · Cited by 91 · see citing works

A distinct microbiota signature precedes the clinical diagnosis of hepatocellular carcinoma

Yang, J., He, Q., Lü, F., Chen, K., Ni, Z., Wang, H., Zhou, C., Zhang, Y., Chen, B., Bo, Z., et al. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2201159 · Cited by 90 · see citing works

Bile acids-gut microbiota crosstalk contributes to the improvement of type 2 diabetes mellitus

Gao, R., Meng, X., Xue, Y., Mao, M., Liu, Y., Tian, X., Sui, B., Li, X., & Zhang, P. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1027212 · Cited by 84 · see citing works

Mitochondrial Dysfunction in Metabolic Dysfunction Fatty Liver Disease (MAFLD)

Zhao, Y., Zhou, Y., Wang, D., Huang, Z., Xiao, X., Zheng, Q., Li, S., Long, D., & Feng, L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417514 · Cited by 86 · see citing works

Amlodipine, an anti‐hypertensive drug, alleviates non‐alcoholic fatty liver disease by modulating gut microbiota

Li, Y., Zhao, D., Qian, M., Liu, J., Pan, C., Zhang, X., Duan, X., Zhang, Y., Jia, W., & Wang, L. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15768 · Cited by 82 · see citing works

Maternal consumption of a fermented diet protects offspring against intestinal inflammation by regulating the gut microbiota

Wang, C., Wei, S., Liu, B., Wang, F., Lu, Z., Jin, M., & Wang, Y. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2057779 · Cited by 78 · see citing works

MDG, an Ophiopogon japonicus polysaccharide, inhibits non-alcoholic fatty liver disease by regulating the abundance of Akkermansia muciniphila

Zhang, L. R., Wang, Y., Wu, F., Wang, X., Feng, Y., & Wang, Y. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.12.036 · Cited by 73 · see citing works

Gut microbes in metabolic disturbances. Promising role for therapeutic manipulations?

Portincasa, P., Khalil, M., Graziani, A., Frühbeck, G., Baffy, G., Garruti, G., Ciaula, A. D., & Bonfrate, L. (2023) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2023.10.002 · Cited by 74 · see citing works

Function of Akkermansia muciniphila in type 2 diabetes and related diseases

Li, J., Yang, G., Zhang, Q., Liu, Z., Jiang, X. M., & Xin, Y. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1172400 · Cited by 71 · see citing works

The interaction of Helicobacter pylori with cancer immunomodulatory stromal cells: New insight into gastric cancer pathogenesis

Navashenaq, J. G., Shabgah, A. G., Banach, M., Jamialahmadi, T., Penson, P. E., Johnston, T. P., & Sahebkar, A. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.09.014 · Cited by 67 · see citing works

Serum metabolite profiling yields insights into health promoting effect of A. muciniphila in human volunteers with a metabolic syndrome

Depommier, C., Everard, A., Druart, C., Maiter, D. M., Thissen, J., Loumaye, A., Hermans, M. P., Delzenne, N. M., de Vos, W. M., & Cani, P. D. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1994270 · Cited by 57 · see citing works

Unraveling the gut microbiota’s role in obesity: key metabolites, microbial species, and therapeutic insights

Iqbal, M., Yu, Q., Tang, J.-Q., & Xiang, J.-J. (2025) · Journal of Bacteriology · doi:10.1128/jb.00479-24 · Cited by 60 · see citing works

Native and Engineered Probiotics: Promising Agents against Related Systemic and Intestinal Diseases

Shen, H., Zhao, Z., Zhao, Z., Chen, Y., & Zhang, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020594 · Cited by 52 · see citing works

Depletion of Gut Microbiota Inhibits Hepatic Lipid Accumulation in High-Fat Diet-Fed Mice

Han, H. L., Wang, M., Zhong, R., Yi, B., Schroyen, M., & Zhang, H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23169350 · Cited by 49 · see citing works

Breaking down barriers: is intestinal mucus degradation by Akkermansia muciniphila beneficial or harmful?

Tingler, A. M., & Engevik, M. A. (2025) · Infection and Immunity · doi:10.1128/iai.00503-24 · Cited by 53 · see citing works

Akkermansia muciniphila and Bifidobacterium bifidum Prevent NAFLD by Regulating FXR Expression and Gut Microbiota

Nian, F., Wu, L., Xia, Q., Tian, P., Ding, C., & Lu, X. (2023) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2022.00415 · Cited by 49 · see citing works

Gut Microbiota Ecosystem Governance of Host Inflammation, Mitochondrial Respiration and Skeletal Homeostasis

Lian, W., Wang, F., Chen, Y., Tsai, M., Chao, H., Jahr, H., Wu, R., & Ko, J. (2022) · Biomedicines · doi:10.3390/biomedicines10040860 · Cited by 45 · see citing works

Dietary Influences on Gut Microbiota and Their Role in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Hamamah, S., Iatcu, O. C., & Covașă, M. (2024) · Nutrients · doi:10.3390/nu17010143 · Cited by 44 · see citing works

Akkermansia muciniphila suppressing nonalcoholic steatohepatitis associated tumorigenesis through CXCR6+ natural killer T cells

Li, T., Lin, X., Shen, B., Zhang, W., Liu, Y., Liu, H., Wang, Y., Zheng, L., & Zhi, F. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1047570 · Cited by 42 · see citing works

Health and Disease:Akkermansia muciniphila, the Shining Star of the Gut Flora

Xue, C., Li, G., Gu, X., Su, Y., Zheng, Q., Yuan, X. H., Bao, Z., Lu, J., & Li, L. (2023) · Research · doi:10.34133/research.0107 · Cited by 43 · see citing works

Multi-omics reveals deoxycholic acid modulates bile acid metabolism via the gut microbiota to antagonize carbon tetrachloride-induced chronic liver injury

Zhang, L. R., Zheng, Z., Huang, H., Fu, Y., Chen, T., Liu, C., Yi, Q., Lin, C., Zeng, Y., Ou, Q., et al. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2323236 · Cited by 42 · see citing works

Network mapping of root–microbe interactions in Arabidopsis thaliana

He, X., Zhang, Q., Li, B., Jin, Y., Jiang, L., & Wu, R. (2021) · npj Biofilms and Microbiomes · doi:10.1038/s41522-021-00241-4 · Cited by 41 · see citing works

Role of Akkermansia muciniphila in the development of nonalcoholic fatty liver disease: current knowledge and perspectives

Han, Y., Li, L., & Wang, B. (2022) · Frontiers of Medicine · doi:10.1007/s11684-022-0960-z · Cited by 41 · see citing works

The Role of Akkermansia muciniphila on Improving Gut and Metabolic Health Modulation: A Meta-Analysis of Preclinical Mouse Model Studies

Khalili, L., Park, G., Nagpal, R., & Salazar, G. (2024) · Microorganisms · doi:10.3390/microorganisms12081627 · Cited by 40 · see citing works

Gut microbiome and metabolome signatures in liver cirrhosis-related complications

Sharma, S. P., Gupta, H., Kwon, G.-H., Lee, S., Song, S. H., Kim, J. S., Park, J. H., Kim, M. J., Yang, D., Park, H., et al. (2024) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2024.0349 · Cited by 39 · see citing works

Gut microbial enzymes and metabolic dysfunction-associated steatohepatitis: Function, mechanism, and therapeutic prospects

Luo, X., Wang, K., & Jiang, C. (2025) · Cell Host & Microbe · doi:10.1016/j.chom.2025.04.020 · Cited by 41 · see citing works

The role of hypoxia-inducible factor 1α in hepatic lipid metabolism

Luo, M., Li, T., & Sang, H. (2023) · Journal of Molecular Medicine · doi:10.1007/s00109-023-02308-5 · Cited by 38 · see citing works

Consecutive fecal microbiota transplantation for metabolic dysfunction-associated steatotic liver disease: a randomized controlled trial

Groenewegen, B., Ruissen, M. M., Crossette, E. M., Menon, R., Prince, A., Norman, J. M., Ballieux, B. E. P. B., Lamb, H. J., Terveer, E. M., Keller, J. J., et al. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2541035 · Cited by 42 · see citing works

Association of Gut Microbiota With Intestinal Ischemia/Reperfusion Injury

Chen, J., Wang, Y. H. D., Shi, Y., Liu, Y., Wu, C., & Luo, Y. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.962782 · Cited by 37 · see citing works

Multiomics Study Reveals Enterococcus and Subdoligranulum Are Beneficial to Necrotizing Enterocolitis

Lin, H., Guo, Q., Ran, Y., Lin, L., Chen, P., He, J., Chen, Y., & Wen, J. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.752102 · Cited by 37 · see citing works

Maternal Betaine Supplementation Mitigates Maternal High Fat Diet-Induced NAFLD in Offspring Mice through Gut Microbiota

Sun, L., Tan, X., Liang, X., Chen, H., Ou, Q., Wu, Q., Yu, X., Zhao, H., Huang, Q., Yi, Z., et al. (2023) · Nutrients · doi:10.3390/nu15020284 · Cited by 36 · see citing works

Gut microbiota-mediated modulation of host amino acid availability and metabolism

Han, Z., Zhao, L., Hu, Q., Hung, I., Liu, C., Liu, S., Mei, X., Zeng, X., Bin, P., & Wang, J. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2552345 · Cited by 42 · see citing works

Akkermansia Muciniphila Ameliorates Chronic Kidney Disease Interstitial Fibrosis Via the Gut-Renal Axis

Pei, T., Hu, R., Wang, F., Yang, S., Feng, H., Li, Q., Zhang, J., Yan, S., Ju, L., He, Z., et al. (2022) · Microbial Pathogenesis · doi:10.1016/j.micpath.2022.105891 · Cited by 35 · see citing works

Brain-gut-liver axis: Chronic psychological stress promotes liver injury and fibrosis via gut in rats

Xu, M.-Y., Guo, C.-C., Li, M., Lou, Y.-H., Chen, Z., Liu, B., & Lan, L. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.1040749 · Cited by 35 · see citing works

Modulation of gut microbiota and lipid metabolism in rats fed high-fat diets by Ganoderma lucidum triterpenoids

Tong, A., Wu, W., Chen, Z., Wen, J., Jia, R., Liu, B., Cao, H., & Zhao, C. (2022) · Current Research in Food Science · doi:10.1016/j.crfs.2022.100427 · Cited by 35 · see citing works

Unraveling the Gut–Liver–Brain Axis: Microbiome, Inflammation, and Emerging Therapeutic Approaches

Aghara, H., Patel, M., Chadha, P., Parwani, K., Chaturvedi, R., & Mandal, P. (2025) · Mediators of Inflammation · doi:10.1155/mi/6733477 · Cited by 35 · see citing works

Gut Microbiota‐Derived 3‐Hydroxybutyrate Blocks GPR43‐Mediated IL6 Signaling to Ameliorate Radiation Proctopathy

Ge, Z., Chen, C., Chen, J., Zhou, J., Chen, L., Wei, Y., Chen, H., He, L., Zou, Y., Long, X., et al. (2024) · Advanced Science · doi:10.1002/advs.202306217 · Cited by 36 · see citing works

Crucial functions of gut microbiota on gut–liver repair

Wang, Y., Yan, H., Zheng, Q., & Sun, X. (2025) · hLife · doi:10.1016/j.hlife.2025.01.001 · Cited by 34 · see citing works

The role of Akkermansia muciniphila in maintaining health: a bibliometric study

Gao, F., Cheng, C., Li, R., Chen, Z., Tang, K., & Du, G. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1484656 · Cited by 38 · see citing works

Bacterial extracellular vesicles for gut microbiome–host communication and drug development

Qian, D., Xu, P., Wang, X., Du, C., Zhao, X., & Xu, J. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.03.008 · Cited by 36 · see citing works

Akkermansia muciniphila exacerbates acute radiation–induced intestinal injury by depleting mucin and enhancing inflammation

Wang, Y., Wang, X., Chen, Z., Zheng, J., Liu, X., Zheng, Y., Zheng, Z., Xu, Z., Zhang, Y., Chen, K., et al. (2025) · The ISME Journal · doi:10.1093/ismejo/wraf084 · Cited by 34 · see citing works

Molecular Aspects of MAFLD—New Insights on Pathogenesis and Treatment

Filipović, B. F., Marjanovic-Haljilji, M., Mijac, D. D., Lukić, S., Kapor, S., Kapor, S., Starčević, A., Popovic, D. D., & Djoković, A. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45110573 · Cited by 34 · see citing works

Multi-omics data reveals the disturbance of glycerophospholipid metabolism and linoleic acid metabolism caused by disordered gut microbiota in PM2.5 gastrointestinal exposed rats

Zhang, Y., Li, M., Pu, Z., Chi, X., & Yang, J. (2023) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2023.115182 · Cited by 33 · see citing works

Toxic effects of nanoplastics and microcystin-LR coexposure on the liver-gut axis of Hypophthalmichthys molitrix

Zhang, C., Bao, F., Wang, F., Xue, Z., & Lin, D. (2024) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2024.170011 · Cited by 33 · see citing works

Bacteroides plebeius improves muscle wasting in chronic kidney disease by modulating the gut‐renal muscle axis

Pei, T., Zhu, D., Yang, S., Hu, R., Wang, F., Zhang, J., Yan, S., Ju, L., He, Z., Han, Z., et al. (2022) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17626 · Cited by 35 · see citing works

Pectin in Metabolic Liver Disease

Hu, W., Cassard, A., & Ciocan, D. M. (2022) · Nutrients · doi:10.3390/nu15010157 · Cited by 34 · see citing works

The effects of rhein on D-GalN/LPS-induced acute liver injury in mice: Results from gut microbiome-metabolomics and host transcriptome analysis

Liu, S., Yin, R., Yang, Z., Wei, F., & Hu, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.971409 · Cited by 33 · see citing works

Gut microbiota, immunity, and bile acid metabolism: decoding metabolic disease interactions

Zhao, Q., Wu, J., Ding, Y., Pang, Y., & Jiang, C. (2023) · Life Metabolism · doi:10.1093/lifemeta/load032 · Cited by 31 · see citing works

Surface-Displayed Amuc_1100 From Akkermansia muciniphila on Lactococcus lactis ZHY1 Improves Hepatic Steatosis and Intestinal Health in High-Fat-Fed Zebrafish

Zhang, F.-L., Yang, Y., Zhang, Z., Yao, Y., Xia, R., Gao, C., Du, D., Hu, J., Ran, C., Liu, Z., et al. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.726108 · Cited by 32 · see citing works

Therapeutic modulation of the liver immune microenvironment

Tilg, H., Adolph, T. E., & Tacke, F. (2023) · Hepatology · doi:10.1097/hep.0000000000000386 · Cited by 31 · see citing works

The Microbiota and It’s Correlation With Metabolites in the Gut of Mice With Nonalcoholic Fatty Liver Disease

Gu, C., Zhou, Z., Yu, Z., He, M., He, L., Luo, Z., Xiao, W., Yang, Q., Zhao, F., Li, W., et al. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.870785 · Cited by 30 · see citing works

The role of microbiomes in gastrointestinal cancers: new insights

Yarahmadi, A., & Afkhami, H. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2023.1344328 · Cited by 30 · see citing works

Role of Akkermansia muciniphila in insulin resistance

Zeng, Z., Chen, M., Liu, Y., Zhou, Y., Liu, H., Wang, S., & Ji, Y. (2024) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.16747 · Cited by 29 · see citing works

Daily Dose of Bovine Lactoferrin Prevents Ethanol‐Induced Liver Injury and Death in Male Mice by Regulating Hepatic Alcohol Metabolism and Modulating Gut Microbiota

Li, D., Qian, H., Yang, H., Du, Y., Yu, K., Yang, J., Tong, X., Guo, Y., Xu, J., & Qin, L. (2021) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202100253 · Cited by 29 · see citing works

Vitamin C and vitamin D3 alleviate metabolic-associated fatty liver disease by regulating the gut microbiota and bile acid metabolism via the gut-liver axis

Chen, Q., Zhao, L., Mei, L., Zhao, X., Han, P., Liu, J., Meng, C., Li, R., Zhong, R., Wang, K., et al. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1163694 · Cited by 29 · see citing works

Akkermansia muciniphila reduces susceptibility to Listeria monocytogenes infection in mice fed a high-fat diet

Keane, J. M., Heras, V. L., Pinheiro, J. C., FitzGerald, J. A., Núñez‐Sánchez, M. Á., Hueston, C. M., O’Mahony, L., Cotter, P. D., Hill, C., Melgar, S., et al. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2229948 · Cited by 29 · see citing works

Gut microbiota: Candidates for a novel strategy for ameliorating sleep disorders

Li, L., Liang, T., Jiang, T., Li, Y., Yang, L., Wu, L., Yang, J., Ding, Y., Wang, J., Chen, M., et al. (2023) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2023.2228409 · Cited by 30 · see citing works

Bifidobacterium longum 070103 Fermented Milk Improve Glucose and Lipid Metabolism Disorders by Regulating Gut Microbiota in Mice

Jiang, T., Li, Y., Li, L., Liang, T., Du, M., Yang, L., Yang, J., Yang, R., Zhao, H., Chen, M., et al. (2022) · Nutrients · doi:10.3390/nu14194050 · Cited by 28 · see citing works

Akkermansia muciniphila: The state of the art, 18 years after its first discovery

Iwaza, R., Wasfy, R. M., Dubourg, G., Raoult, D., & Lagier, J. (2022) · Frontiers in Gastroenterology · doi:10.3389/fgstr.2022.1024393 · Cited by 30 · see citing works

Utility of Human Relevant Preclinical Animal Models in Navigating NAFLD to MAFLD Paradigm

Chua, D., Low, Z. S., Cheam, G. X., Ng, A. S., & Tan, N. S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232314762 · Cited by 30 · see citing works

Tetrastigma hemsleyanum leaf extracts ameliorate NAFLD in mice with low-grade colitis via the gut–liver axis

Xiao, L., Xiong, H., Deng, Z., Peng, X. X., Cheng, K., Zhang, H., Jiang, L., & Sun, Y. (2022) · Food & Function · doi:10.1039/d2fo03028d · Cited by 28 · see citing works

Oat-based postbiotics ameliorate high-sucrose induced liver injury and colitis susceptibility by modulating fatty acids metabolism and gut microbiota

Wei, S., Wen, R., Liu, T., Zhou, L., Wang, G., Dai, X., & Shi, L. S. (2023) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2023.109553 · Cited by 28 · see citing works

The gut-liver axis in fatty liver disease: role played by natural products

Ming, Z., Ruishi, X., Linyi, X., Yonggang, Y., Haoming, L., & Lan, X. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1365294 · Cited by 27 · see citing works

Gut microbiota regulates hepatic ketogenesis and lipid accumulation in ketogenic diet-induced hyperketonemia by disrupting bile acid metabolism

Luo, Z., Huang, Y., Yong, K., Wu, D., Zheng, L., Yao, X., Shen, L., Yu, S., Wang, B., & Cao, S. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2496437 · Cited by 27 · see citing works

The Association Between Fecal Short-Chain Fatty Acids, Gut Microbiota, and Visceral Fat in Monozygotic Twin Pairs

Yin, X.-Q., An, Y.-X., Yu, C.-G., Ke, J., Zhao, D., & Yu, K. (2022) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s338113 · Cited by 27 · see citing works

Short- and Long-Term Effects of Different Antibiotics on the Gut Microbiota and Cytokines Level in Mice

Wang, J., Xiang, Q., Gu, S., Gu, Y., Yao, M., Huang, W., Wang, G. T., & Tang, L. (2022) · Infection and Drug Resistance · doi:10.2147/idr.s388687 · Cited by 27 · see citing works

Therapeutic mechanisms of the medicine and food homology formula Xiao-Ke-Yin on glucolipid metabolic dysfunction revealed by transcriptomics, metabolomics and microbiomics in mice

Li, M., Cheng, D., Peng, C., Huang, Y., Geng, J., Huang, G., Wang, T., & Xu, A. (2023) · Chinese Medicine · doi:10.1186/s13020-023-00752-6 · Cited by 27 · see citing works

Indole-3-propionic acid alleviates sepsis-associated acute liver injury by activating pregnane X receptor

Wang, S., Xiong, L., Ruan, Z., Gong, X., Luo, Y., Wu, C., Wang, Y., Shang, H. F., & Chen, J. (2023) · Molecular Medicine · doi:10.1186/s10020-023-00658-x · Cited by 27 · see citing works

Gut Microbiome Modulation in Hepatocellular Carcinoma: Preventive Role in NAFLD/NASH Progression and Potential Applications in Immunotherapy-Based Strategies

Monti, E., Vianello, C., Leoni, I., Galvani, G., Lippolis, A., D’Amico, F., Roggiani, S., Stefanelli, C., Turroni, S., & Fornari, F. (2025) · Cells · doi:10.3390/cells14020084 · Cited by 26 · see citing works

Reconsidering Meat Intake and Human Health: A Review of Current Research

Xie, Y., Ma, Y., Cai, L., Jiang, S., & Li, C. (2022) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202101066 · Cited by 26 · see citing works

Gut Microbiome and Serum Metabolome Profiles of Capsaicin with Cognitive Benefits in APP/PS1 Mice

Li, J., Liao, X., Yin, X., Deng, Z., Hu, G., Zhang, W., Jiang, F., & Zhao, L. (2022) · Nutrients · doi:10.3390/nu15010118 · Cited by 26 · see citing works

Mapping the human oral and gut fungal microbiota in patients with metabolic dysfunction-associated fatty liver disease

Niu, C., Tu, Y., Jin, Q., Chen, Z., Yuan, K., Wang, M., Zhang, P., Luo, J., Li, H., Yang, Y., et al. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1157368 · Cited by 26 · see citing works

Polysaccharide from Panax japonicus C.A. Mey prevents non-alcoholic fatty liver disease development based on regulating liver metabolism and gut microbiota in mice

Wu, Y., Yin, W., Hao, P., Chen, Y., Yu, L., Yu, X., Wu, Y., Li, X., Wang, W., Zhou, H., et al. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.129430 · Cited by 26 · see citing works

Inflammatory Indices and MAFLD Prevalence in Hypertensive Patients: A Large-Scale Cross-Sectional Analysis from China

Shen, D., Cai, X., Hu, J., Song, S., Zhu, Q., Ma, H., Zhang, Y., Ma, R., Zhou, P., Yang, W., et al. (2025) · Journal of Inflammation Research · doi:10.2147/jir.s503648 · Cited by 25 · see citing works

Novel microbially transformed bile acids: Biosynthesis, structure, and function

Zhao, Q., Duan, Z., Lai, R., & Ma, P. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107775 · Cited by 25 · see citing works

Leveraging host-genetics and gut microbiota to determine immunocompetence in pigs

Ramayo‐Caldas, Y., Zingaretti, L. M., Pérez-Pascual, D., Alexandre, P. A., Reverter, A., Dalmau, A., Quintanilla, R., & Ballester, M. (2021) · Animal Microbiome · doi:10.1186/s42523-021-00138-9 · Cited by 25 · see citing works

The gut microbiota: an emerging modulator of drug resistance in hepatocellular carcinoma

Yao, J., Ning, B., & Ding, J. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2473504 · Cited by 25 · see citing works

Function and therapeutic potential of Amuc_1100, an outer membrane protein of Akkermansia muciniphila: A review

Wu, X., Yu, D., Ma, Y., Fang, X., & Sun, P. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.142442 · Cited by 24 · see citing works

Matrine counteracts obesity in mice via inducing adipose thermogenesis by activating HSF1/PGC-1α axis

Li, C., Xu, Y., Hu, Y., Zhou, X., Huang, Z., Ye, J., & Rao, Y. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106136 · Cited by 24 · see citing works

Integrating metabonomics and metagenomics sequencing to study the anti-liver fibrosis effects of palmatine in Corydalis saxicola Bunting

Qin, J., Luo, Z., Wang, Q., Tang, C., Meng, M., Huang, Z., Guo, B., He, Y., Feng, L., Nong, Y., et al. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.116666 · Cited by 24 · see citing works

Special correlation between diet and MASLD: positive or negative?

Liu, J., Li, C., Yang, Y., Li, J., Sun, X., Zhang, Y., Liu, R., Chen, F., & Li, X. (2025) · Cell & Bioscience · doi:10.1186/s13578-025-01382-1 · Cited by 23 · see citing works

Antagonism Between Gut Ruminococcus gnavus and Akkermansia muciniphila Modulates the Progression of Chronic Hepatitis B

Chua, H., Chen, Y., Wu, L., Yang, H., Lin, C.-R., Chen, H., Wu, J., Chang, M., Chen, P., & Ni, Y. (2023) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2023.12.003 · Cited by 23 · see citing works

Application of intelligent tongue image analysis in Conjunction with microbiomes in the diagnosis of MAFLD

Dai, S., Guo, X., Liu, S., Tu, L., Hu, X., Cui, J. W., Ruan, Q., Tan, X., Lü, H., Jiang, T., et al. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e29269 · Cited by 22 · see citing works

Hyperoxia Provokes Time- and Dose-Dependent Gut Injury and Endotoxemia and Alters Gut Microbiome and Transcriptome in Mice

Li, Y., Tao, Y., Xu, J., He, Y.-H., Zhang, W., Jiang, Z.-G., He, Y., Liu, H., Chen, M., Zhang, W., et al. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.732039 · Cited by 22 · see citing works

Multiomics reveals microbial metabolites as key actors in intestinal fibrosis in Crohn’s disease

Li, X.-H., Hu, S., Shen, X.-D., Zhang, R.-N., Liu, C.-G., Xiao, L., Lin, J.-J., Huang, L., He, W.-T., Wang, X., et al. (2024) · EMBO Molecular Medicine · doi:10.1038/s44321-024-00129-8 · Cited by 22 · see citing works

Gut Akkermansia muciniphila ameliorates non-alcoholic fatty liver disease by L-aspartate via interaction with liverPreprint

Rao, Y., Kuang, Z., Li, C., Guo, S., Xu, Y., Zhao, D., Hu, Y., Song, B., Jiang, Z. D., Ge, Z., et al. (2020) · doi:10.22541/au.160225760.01320126/v1 · Cited by 1 · see citing works

<i>Akkermansia muciniphila</i> alleviates <scp>high‐fat‐diet</scp> ‐related metabolic‐associated fatty liver disease by modulating gut microbiota and bile acids

Wu, W., Kaicen, W., Bian, X., Yang, L., Ding, S., Li, Y., Li, S., Zhuge, A., & Li, L. (2023) · Microbial Biotechnology · doi:10.1111/1751-7915.14293 · Cited by 129 · see citing works

Lactobacillus mucosae extracellular vesicles improve metabolic dysfunction-associated fatty liver disease by activating the AMPK pathway via the gut-liver axis

Zhang, K. C., Zeng, Y., Liao, Z., Wu, J., Zhang, X., Chen, T., & Xie, Z. (2026) · Journal of Nanobiotechnology · doi:10.1186/s12951-026-04843-y

Arctigenin-mediated gut microbiota and metabolite butyric acid positively affect the intestinal barrier and hepatic lipid metabolism in diet-induced metabolic dysfunction-associated fatty liver disease

Wang, N., Cao, X., Wang, C., & Zhang, Z. (2025) · Food Science and Human Wellness · doi:10.26599/fshw.2025.9250561

Intestinal microbiota in the treatment of metabolically associated fatty liver disease

Wang, J.-S., & Liu, J. (2022) · World Journal of Clinical Cases · doi:10.12998/wjcc.v10.i31.11240 · Cited by 8 · see citing works